BeOne Medicines is a global oncology company dedicated to discovering, developing, and commercializing transformative cancer medicines. They focus on advancing a broad pipeline through rigorous science, including pioneering protein degradation with CDACs and antibody drug conjugates, to serve patients worldwide. BeOne Medicines aims to build the world's leading oncology company, driven by scientific excellence and speed to reach more patients.